Evaluating translocation gene fusions by SNP array data

Cancer Informatics

Volumn 11, Issue , 2012, Pages 15-27

  Liu, Hong ^a   Zilberstein, Asher ^a   Pannier, Pascal ^a   Fleche, Frederic ^a   Arendt, Christopher ^a   Lengauer, Christoph ^a   Hahn, Chang S ^a  

^a SANOFI   (France)

Author keywords

Copy number breakpoint; Copy number variation; SNP array; Translocation

Indexed keywords

ARTICLE; BCR ABL1 GENE; CANCER CELL CULTURE; CARCINOGENESIS; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; COPY NUMBER VARIATION; EML4 ALK GENE; FUSION GENE; GENE TRANSLOCATION; GENETIC ASSOCIATION; GENETIC LINKAGE; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; MALE; MOLECULAR PATHOLOGY; ONCOGENE; PREDICTION; PROSTATE CANCER; SINGLE NUCLEOTIDE POLYMORPHISM; TMPRSS2 ERG GENE;

EID: 84863137387     PISSN: None     EISSN: 11769351     Source Type: Journal    
DOI: 10.4137/CIN.S8026     Document Type: Article

References (31)

1. Soda M, Choi YL, et al. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature. 2007;448(7153):561-6.
2. Mertens F, Antonescu CR, et al. Translocation-related sarcomas. Semin Onco. 2009;l36(4):312-23.
3. MacDonald JW, Ghosh D. COPA-cancer outlier profile analysis. Bioinformatics. 2006;22(23):2950-1.
4. Tomlins SA, Rhodes DR, et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science. 2005;310(5748):644-8.
5. Maher CA, Kumar-Sinha C, et al. Transcriptome sequencing to detect gene fusions in cancer. Nature. 2009;458(7234):97-101.
6. Nickoloff JA, De Haro LP, et al. Mechanisms of leukemia translocations. Curr Opin Hematol. 2008;15(4):338-45.
7. Kurzrock R, Kantarjian HM, et al. Philadelphia chromosome-positive leukemias: from basic mechanisms to molecular therapeutics. Ann Intern Med. 2003;138(10):819-30.
8. Uphoff CC, Habig S, et al. ABL-BCR expression in BCR-ABL-positive human leukemia cell lines. Leuk Res. 1999;23(11):1055-60.
9. Rajput AB, Miller MA, et al. Frequency of the TMPRSS2:ERG gene fusion is increased in moderate to poorly differentiated prostate cancers. J Clin Pathol. 2007;60(11):1238-43.
10. Rikova K, Guo A, et al. Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer. Cell. 2007;131(6):1190-203.
11. Shtivelman E, Henglein B, et al. Identification of a human transcription unit affected by the variant chromosomal translocations 2;8 and 8;22 of Burkitt lymphoma. Proc Natl Acad Sci U S A. 1989;86(9):3257-60.
12. Boland E, Clayton-Smith J, et al. Mapping of deletion and translocation breakpoints in 1q44 implicates the serine/threonine kinase AKT3 in postnatal microcephaly and agenesis of the corpus callosum. Am J Hum Genet. 2007;81(2):292-303.
13. Gajecka M, Glotzbach CD, et al. Identification of cryptic imbalance in phenotypically normal and abnormal translocation carriers. Eur J Hum Genet. 2006;14(12):1255-62.
14. Iijima Y, Ito T, et al. A new ETV6/TEL partner gene, ARG (ABL-related gene or ABL2), identified in an AML-M3 cell line with a t(1;12)(q25;p13) translocation. Blood. 2000;95(6):2126-31.
15. Skalova A, Vanecek T, et al. Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity. Am J Surg Pathol. 2010;34(5): 599-608.
16. Eguchi M, Eguchi-Ishimae M, et al. Fusion of ETV6 to neurotrophin-3 receptor TRKC in acute myeloid leukemia with t(12;15)(p13;q25). Blood. 1999;93(4):1355-63.
17. Lin E, Li L, et al. Exon array profiling detects EML4-ALK fusion in breast, colorectal, and non-small cell lung cancers. Mol Cancer Res. 2009;7(9): 1466-76.
18. Croce CM. Oncogenes and cancer. N Engl J Med. 2008;358(5):502-11.
19. Bastus NC, Boyd LK, et al. Androgen-induced TMPRSS2:ERG fusion in nonmalignant prostate epithelial cells. Cancer Res. 2010;70(23):9544-8.
20. Mwamukonda K, Chen Y, et al. Quantitative expression of TMPRSS2 transcript in prostate tumor cells reflects TMPRSS2-ERG fusion status. Prostate Cancer Prostatic Dis. 2010;13(1):47-51.
21. Stephens PJ, McBride DJ, et al. Complex landscapes of somatic rearrangement in human breast cancer genomes. Nature. 2009;462(7276):1005-10.
22. Gemmill RM, West JD, et al. The hereditary renal cell carcinoma 3;8 translocation fuses FHIT to a patched-related gene, TRC8. Proc Natl Acad Sci U S A. 1998;95(16):9572-7.
23. Belloso JM, Bache I, et al. Disruption of the CNTNAP2 gene in a t(7;15) translocation family without symptoms of Gilles de la Tourette syndrome. Eur J Hum Genet. 2007;15(6):711-3.
24. Berger MF, Lawrence MS, et al. The genomic complexity of primary human prostate cancer. Nature. 2011;470(7333):214-20.
25. Moller RS, Kubart S, et al. Truncation of the Down syndrome candidate gene DYRK1A in two unrelated patients with microcephaly. Am J Hum Genet. 2008;82(5):1165-70.
26. Strick R, Zhang Y, et al. Common chromatin structures at breakpoint cluster regions may lead to chromosomal translocations found in chronic and acute leukemias. Hum Genet. 2006;119(5):479-95.
27. Zhang Y, Rowley JD. Chromatin structural elements and chromosomal translocations in leukemia. DNA Repair (Amst). 2006;5(9-10):1282-97.
28. Choi YL, Soda M, et al. EML4-ALK mutations in lung cancer that confer resistance to ALK inhibitors. N Engl J Med. 2010;363(18):1734-9.
29. Kwak EL, Bang YJ, et al. Anaplastic lymphoma kinase inhibition in nonsmall- cell lung cancer. N Engl J Med. 2010;363(18):1693-703.
30. Gerber DE, Minna JD. ALK inhibition for non-small cell lung cancer: from discovery to therapy in record time. Cancer Cell. 2010;18(6):548-51.
31. Berger MF, Levin JZ, et al. Integrative analysis of the melanoma transcriptome. Genome Res. 2010;20(4):413-27.